CD4 and neoplasm: In addition, because the tumor stroma supports cancer cell drug resistance (7, 48), our data suggest that CD4-based immunotherapy could act synergistically with chemoradiotherapy and radiotherapy by weakening the supporting role of TAMs and thus making the cancer cells more susceptible to the therapeutic agents.